JPH01100113A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPH01100113A JPH01100113A JP25673687A JP25673687A JPH01100113A JP H01100113 A JPH01100113 A JP H01100113A JP 25673687 A JP25673687 A JP 25673687A JP 25673687 A JP25673687 A JP 25673687A JP H01100113 A JPH01100113 A JP H01100113A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- kojic acid
- external preparation
- protein
- kojic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960004705 kojic acid Drugs 0.000 claims abstract description 27
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 27
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 150000002148 esters Chemical class 0.000 claims abstract description 10
- 238000000354 decomposition reaction Methods 0.000 claims description 7
- 235000018102 proteins Nutrition 0.000 abstract description 11
- 239000006071 cream Substances 0.000 abstract description 8
- 239000006210 lotion Substances 0.000 abstract description 8
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 239000000839 emulsion Substances 0.000 abstract description 5
- 239000002674 ointment Substances 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 5
- 108010035532 Collagen Proteins 0.000 abstract description 4
- 102000008186 Collagen Human genes 0.000 abstract description 4
- 229920001436 collagen Polymers 0.000 abstract description 4
- 239000002932 luster Substances 0.000 abstract description 4
- URJOWNUVTORLNY-UHFFFAOYSA-N (5-hexadecanoyloxy-4-oxopyran-2-yl) hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=CO1 URJOWNUVTORLNY-UHFFFAOYSA-N 0.000 abstract description 3
- 108010073771 Soybean Proteins Proteins 0.000 abstract description 3
- 239000000865 liniment Substances 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 235000019710 soybean protein Nutrition 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 1
- 229940040145 liniment Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- -1 Polyoxyethylene Polymers 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical group OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は美白作用を有すると共に使用感がよく、肌にな
じみ、肌になめらかなつやを与える皮膚外用剤に関する
。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a skin preparation for external use that has a whitening effect, is comfortable to use, blends well with the skin, and gives smooth luster to the skin.
[従来の技術]
皮膚外用剤はローション、乳液、クリーム、パウダーな
どの形で化粧料や乳剤、リニメント剤、軟膏剤などに使
用されている。これらの皮膚外用剤は直接皮膚に塗布さ
れるので、皮膚との親和性や使用感が重要な性質とされ
ている。[Prior Art] External skin preparations are used in cosmetics, emulsions, liniments, ointments, etc. in the form of lotions, milky lotions, creams, and powders. Since these external skin preparations are applied directly to the skin, their affinity with the skin and the feeling of use are considered important properties.
一方、コウジ酸またはそのエステルが安全で強い美白作
用を有していることも知られている。On the other hand, it is also known that kojic acid or its esters are safe and have strong whitening effects.
[発明が解決しようとする問題点]
本発明は、コウジ酸またはそのエステルを用いた皮膚外
用剤が、従来の通常の処方では使用感や肌の状態におい
て必ずしも良好ではない点に鑑みなされたものであり、
塗布時のベタツキがなく、肌によくなじみ、肌をなめら
かにし、かつつやを与える皮膚外用剤を提供することを
目的とするものである。[Problems to be Solved by the Invention] The present invention was developed in view of the fact that the conventional formulation of external skin preparations using kojic acid or its esters does not necessarily provide a good feeling of use and skin condition. and
The object of the present invention is to provide a skin preparation for external use that is not sticky when applied, blends well into the skin, makes the skin smooth, and gives a glossy glow.
[問題点を解決するための手段]
かかる目的は、タンパク質またはその分解物の1種また
は2種以上とコウジ酸またはそのエステルの18または
2種以上とを含有させることにより達成される。[Means for Solving the Problems] This object is achieved by containing one or more types of proteins or decomposition products thereof and 18 or more types of kojic acid or esters thereof.
[作用および実施例コ
本発明における一方の成分であるコウジ酸またはそのエ
ステルとしては、一般式:
(式中、R1およびR2は同じかまたは異なり、水素原
子または炭素数3〜20個のアシル基である)で示され
るものが好ましい。[Function and Examples] Kojic acid or its ester, which is one of the components in the present invention, has the general formula: ) are preferred.
エステルとしては、コウジ酸モノブチレート、コウジ酸
モノカプレート、コウジ酸モノパルミテート、コウジ酸
モノステアレート、コウジ酸モノシンナモエートまたは
コウジ酸モノベンゾエートなどのモノエステル、コウジ
酸ジブチレート、コウジ酸ジパルミテート、コウジ酸ジ
ステアレートまたはコウジ酸ジオレエートなどのジエス
テルが好ましい。モノエステルはコウジ酸の5位の水酸
基がエステル化されているものが好ましい。エステル化
するとメラニン生成抑制作用はコウジ酸と同等であるが
、pHや光に対する安定性が向上する。これらは、単独
で使用しても併用してもよい。As esters, monoesters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid monostearate, kojic acid monocinnamoate or kojic acid monobenzoate, kojic acid dibutyrate, kojic acid dipalmitate, Diesters such as kojic acid distearate or kojic acid dioleate are preferred. The monoester is preferably one in which the hydroxyl group at the 5-position of kojic acid is esterified. When esterified, the melanin production inhibiting effect is equivalent to that of kojic acid, but the stability against pH and light is improved. These may be used alone or in combination.
他の成分であるタンパク質またはその分解物を皮膚外用
剤の配合成分として用いることも知られているが、所望
の効果をうるためには多量に配合する必要があり、多量
に用いると塗布時にベタツキが生じたり肌へのなじみが
わるくなることがある。しかし、このようなタンパク質
またはその分解物であってもコウジ酸またはそのエステ
ルと配合するときは塗布時のベタツキが抑えられ、肌へ
のすぐれた親和性と使用感を長期間保持することができ
る。It is also known that proteins or their decomposition products, which are other ingredients, can be used as ingredients in external skin preparations, but in order to obtain the desired effect, they must be added in large amounts, and if used in large amounts, they may become sticky when applied. This may cause irritation or the product may not absorb well into the skin. However, when such proteins or their decomposition products are combined with kojic acid or its esters, stickiness during application is suppressed, and excellent affinity for the skin and feeling of use can be maintained for a long period of time. .
タンパク質またはその分解物としては、たとえば大豆タ
ンパク、小麦タンパク、グルテリン、グルカゴン、コラ
ーゲン、ゼラチン、エラスチン、卵白リゾチーム、フィ
ブリノーゲン、ミオシン、カゼイン、魚肉タンパクおよ
びそれらの塩などの1種または2種以上があげられ、こ
れらのタンパク質またはその分解物は単独で使用しても
併用してもよい。コウジ酸またはそのエステルの配合量
は外用剤中、通常0.01〜20%(重量%、以下同様
)好ましくは0.1〜2%であり、タンパク質またはそ
の分解物の配合量は通常0.01〜20%、好ましくは
0.1−10%である。Examples of proteins or their decomposition products include one or more of soybean protein, wheat protein, glutelin, glucagon, collagen, gelatin, elastin, egg white lysozyme, fibrinogen, myosin, casein, fish protein, and salts thereof. These proteins or their decomposition products may be used alone or in combination. The amount of kojic acid or its ester in the external preparation is usually 0.01 to 20% (by weight, the same applies hereinafter), preferably 0.1 to 2%, and the amount of protein or its decomposition product is usually 0.01 to 20% (by weight, the same applies hereinafter). 01-20%, preferably 0.1-10%.
本発明の外用剤としては、たとえばクリーム、化粧料、
パック、パウダーなどの化粧料のほかに乳剤、ローショ
ン剤、リニメント剤、軟膏剤などの医薬部外品などの種
々の外用形態に製剤にでき、それぞれの製剤において常
用されている基剤、賦形剤、安定剤、顔料、香料、紫外
線吸収剤、酸化防止剤、防腐剤、金属封印剤、有機酸な
どを適宜配合してもよい。External preparations of the present invention include, for example, creams, cosmetics,
In addition to cosmetics such as packs and powders, they can be formulated into various external forms such as emulsions, lotions, liniments, ointments, and other quasi-drugs, and the bases and excipients commonly used in each formulation. Agents, stabilizers, pigments, fragrances, ultraviolet absorbers, antioxidants, preservatives, metal sealants, organic acids, and the like may be added as appropriate.
つぎに実施例をあげて本発明の皮膚外用剤を説明するが
、本発明はかかる実施例のみに限定されるものではない
。Next, the skin external preparation of the present invention will be explained with reference to Examples, but the present invention is not limited to these Examples.
実施例1 (クリーム)
重量部
(A)モノステアリン酸ポリオキシ
エチレングリコール(40E、O,) 2.0
0自己乳化型モノステアリン酸
グリセリン 5.00ステアリン
酸 5.00べl\ニルアルコー
ル 1.00流動パラフイン
1.00トリオクタン酸グリセリル 0.
00コウジ酸ジパルミテート 2.00防腐剤
適量谷 料
微量(B) 1 、3
−ブチレンブリコール 5.00水溶性コラー
ゲン 0゜30精製水
残余(製法)
(A)に属する成分を加熱溶解する(油相)。Example 1 (Cream) Part by weight (A) Polyoxyethylene glycol monostearate (40E, O,) 2.0
0 Self-emulsifying glyceryl monostearate 5.00 Stearic acid 5.00 Benyl alcohol 1.00 Liquid paraffin
1.00 Glyceryl trioctanoate 0.
00 Kojic acid dipalmitate 2.00 Preservative Appropriate amount
Trace amount (B) 1, 3
-Butylene glycol 5.00 Water-soluble collagen 0°30 Purified water
Residue (manufacturing method) The components belonging to (A) are heated and dissolved (oil phase).
別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加し、撹拌乳化後、冷却してクリームをえ
た。Separately, components belonging to (B) are dissolved by heating (aqueous phase). The water phase was added to the oil phase, emulsified by stirring, and then cooled to obtain a cream.
実施例2(ローション)
重量部
ポリオキシエチレン硬化ヒマシ油
(60E、O,) 1.0
0エタノール 15.00クエ
ン酸 0,10クエン酸ナ
トリウム 0,301,3−ブチレン
グリコール 4.00コウジ酸
1.00工ラスチン加水分解物
0.10防腐剤 適
量香 料
微量精製水 残余(製
法)
各成分を均一に撹拌、混合、溶解し、ローションをえた
。Example 2 (Lotion) Part by weight Polyoxyethylene hydrogenated castor oil (60E, O,) 1.0
0 ethanol 15.00 citric acid 0,10 sodium citrate 0,30 1,3-butylene glycol 4.00 kojic acid
1.00 engineering lastine hydrolyzate
0.10 Preservatives Appropriate amount fragrance
Micro-purified water Residue (manufacturing method) Each component was uniformly stirred, mixed, and dissolved to obtain a lotion.
実施例3(乳液)
重量部
(A)ポリオキンエチレンベヘニルエーテル(20E、
O,) 0.50テトラオレイ
ン酸ポリオキシエチレ
ンソルビツト(60E、O) 1.0
0親辿型モノステアリン酸グリセリン 1.00ステア
リン酸 0.50ベヘニルアルコ
ール 0.50アボガト浦
1.00天然ビタミンE
O,02コウジ酸モノパルミテート
2.00防腐剤 適量香
料 微量
(B) 1.3−ブチレングリコール 5.
00カルボキシビニルポリマー 0.10ゼラ
チン 5.00大豆タンパク
0.50精製水
残余(製法)
(A)に属する成分を加熱溶解する(油相)。Example 3 (emulsion) Part by weight (A) Polyoquine ethylene behenyl ether (20E,
O,) 0.50 Polyoxyethylene sorbitate tetraoleate (60E, O) 1.0
0 Glyceryl monostearate 1.00 Stearic acid 0.50 Behenyl alcohol 0.50 Abogatoura
1.00 natural vitamin E
O,02 kojic acid monopalmitate
2.00 Preservatives Appropriate amount of fragrance
Material Trace amount (B) 1.3-Butylene glycol 5.
00 carboxyvinyl polymer 0.10 gelatin 5.00 soy protein 0.50 purified water
Residue (manufacturing method) The components belonging to (A) are heated and dissolved (oil phase).
別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加して撹拌乳化後、冷却して乳液をえた。Separately, components belonging to (B) are dissolved by heating (aqueous phase). The aqueous phase was added to the oil phase, emulsified by stirring, and then cooled to obtain a milky lotion.
実施例4(ゼリー状パック)
重量部
クエン酸 0.20プロピ
レングリコール 4.Oa濃グリセリン
4.00エタノール
2.00カルボキシビニルポリマー
1.00炭酸カリウム 0
.80コウジ酸 0.50カ
ゼイン 6゜00防腐剤
適量香 料
微量精製水
残余(製法)
各成分を撹拌、混合、溶解してゼリー状パックをえた。Example 4 (jelly pack) Part by weight Citric acid 0.20 Propylene glycol 4. Oa concentrated glycerin
4.00 ethanol
2.00 carboxyvinyl polymer
1.00 potassium carbonate 0
.. 80 Kojic acid 0.50 Casein 6゜00 Preservative
Appropriate amount of fragrance
micro purified water
Residue (manufacturing method) Each component was stirred, mixed, and dissolved to obtain a jelly-like pack.
実施例5 (クリーム状パック)
重量部
(Δ)ポリオキシエチレンベヘニルエーテル(20E、
o、) t、o。Example 5 (Cream pack) Part by weight (Δ) Polyoxyethylene behenyl ether (20E,
o,) t, o.
テトラオレイン酸ポリオキシエチレ
ソルビッI−(40F、0.) 2.
00親油型モノステアリン酸グリセリン 2.00ベヘ
ニルアルコール 3.00スクワラン
25.00オクタン酸グリセリ
ン 10.00天然ビタミンE
O,04コウジ酸モノシンナモエート
2.00防腐剤 適
量香 料
微量(B)1.3−ブチレングリコール
5.00小麦タンパク 3.
00クエン酸 0,04コ
ラ一ゲン加水分解物 0.10精製水
残余(製法)
(A)に属する成分を加熱溶解する(油相)。Tetraoleic acid polyoxyethylene sorbitol I-(40F, 0.) 2.
00 Lipophilic glycerin monostearate 2.00 Behenyl alcohol 3.00 Squalane
25.00 Glycerin octoate 10.00 Natural vitamin E
O,04 Kojic acid monocinnamoate
2.00 Preservatives Appropriate amount fragrance
Trace amount (B) 1,3-butylene glycol
5.00 wheat protein 3.
00 Citric acid 0.04 Collagen hydrolyzate 0.10 Purified water
Residue (manufacturing method) The components belonging to (A) are heated and dissolved (oil phase).
別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加して撹拌乳化後、冷却してクリーム状パ
ックをえた。Separately, components belonging to (B) are dissolved by heating (aqueous phase). The aqueous phase was added to the oil phase, emulsified by stirring, and then cooled to obtain a cream pack.
実施例6(軟膏剤)
重量部
(A)モノステアリン酸ポリオキシエチレンソルビタン
([30E、O,) 1.00テトラオ
レイン酸ポリオキシエチレ
ンソルビツト(80E、0.) 1.
50自己乳化型モノステアリン酸グリセ
リン 1.50サラシミ
ツロウ 2.00パラフイン
2.00ステアリン酸
3.00ベヘニルアルコール
3.00シアバター 12.
00流動パラフイン 5.00天然
ビタミンE O,04メチルポ
リシロキサン 0.01コウジ酸モノベン
ゾエート 3.00防腐剤
適量香 料
微量(B) 1 、3−ブチレングリコー
ル 5.00クエン酸
0,30グルテリン
6.00精製水 残余(製
法)
(A)に属する成分を加熱溶解する(油相)。Example 6 (Ointment) Part by weight (A) Polyoxyethylene sorbitan monostearate ([30E, O,) 1.00 Polyoxyethylene sorbitan tetraoleate (80E, 0.) 1.
50 Self-emulsifying glycerin monostearate 1.50 White beeswax 2.00 Paraffin
2.00 stearic acid
3.00 behenyl alcohol
3.00 Shea butter 12.
00 Liquid paraffin 5.00 Natural vitamin E O,04 Methyl polysiloxane 0.01 Kojic acid monobenzoate 3.00 Preservative
Appropriate amount of fragrance
Trace amount (B) 1,3-butylene glycol 5.00 Citric acid
0,30 glutelin
6.00 Purified water Residue (manufacturing method) Heat and dissolve the components belonging to (A) (oil phase).
別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加して撹拌乳化後、冷却して軟膏剤をえた
。Separately, components belonging to (B) are dissolved by heating (aqueous phase). The aqueous phase was added to the oil phase, emulsified by stirring, and then cooled to obtain an ointment.
実施例7(美白パウダー)
重量部
ミリスチン酸オクチルドデシル 1.0コウジ酸
2.0エラスチン
0.5香 料
微量マルチトール
残余(製法)
各成分を均一に撹拌、混合して美白パウダーをえた。Example 7 (whitening powder) Part by weight Octyldodecyl myristate 1.0 Kojic acid
2.0 elastin
0.5 fragrance
trace maltitol
Residue (manufacturing method) Each ingredient was stirred and mixed uniformly to obtain a whitening powder.
実施例8(パネルテスト) 本発明の外用剤の効果をパネルテストにより確認した。Example 8 (panel test) The effectiveness of the external preparation of the present invention was confirmed by a panel test.
女性20名のパネラ−の上腕内側部に本発明の外用剤を
右腕に、対照外用剤を左腕に、1日2回(朝、夜)、3
0日間にわたって単純塗布した。A panel of 20 women applied the topical preparation of the present invention to their right arm and the control topical preparation to their left arm, twice a day (morning and evening), three times a day.
Simple application was performed over a period of 0 days.
試験には実施例1のクリーム、実施例2のローション、
実施例3の乳液を用い、対照品には、それぞれの外用剤
からコウジ酸を除いたものを用いた。The test included the cream of Example 1, the lotion of Example 2,
The emulsion of Example 3 was used, and as a control product, the respective external preparations with kojic acid removed were used.
試験終了後、ぞれの試験部位における塗布時のベタツキ
、肌のなめらかさ、肌へのなじみ、および肌のつやにつ
いて最も優れたものを5、最もわるいものを1とした5
段階で評価し、その平均値をとって比較した。結果を第
1表に示す。After the test, the best one in terms of stickiness during application, skin smoothness, blending into the skin, and skin luster at each test site was given a 5, and the worst one was given a 1.
The results were evaluated in stages, and the average values were taken and compared. The results are shown in Table 1.
[以下余白]
[発明の効果]
本発明の皮膚外用剤によるときは、塗布時のベタツキ、
肌のなめらかさ、肌へのなじみおよび肌のつやなどに好
ましい効果を発揮し、とくにベタツキおよび肌へのなじ
みの改善に著効を示す。[Margin below] [Effects of the invention] When using the skin external preparation of the present invention, there is no stickiness at the time of application,
It exhibits favorable effects on skin smoothness, skin adhesion, and skin luster, and is particularly effective in improving stickiness and skin adhesion.
Claims (1)
とコウジ酸またはそのエステルの1種または2種以上と
を含有する皮膚外用剤。1. A skin external preparation containing one or more proteins or their decomposition products and one or more kojic acid or esters thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62256736A JP2575417B2 (en) | 1987-10-12 | 1987-10-12 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62256736A JP2575417B2 (en) | 1987-10-12 | 1987-10-12 | External preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01100113A true JPH01100113A (en) | 1989-04-18 |
JP2575417B2 JP2575417B2 (en) | 1997-01-22 |
Family
ID=17296729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62256736A Expired - Lifetime JP2575417B2 (en) | 1987-10-12 | 1987-10-12 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2575417B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06256151A (en) * | 1993-03-01 | 1994-09-13 | Maruzen Pharmaceut Co Ltd | Skin cosmetic |
JP2002293738A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Cosmetic for improving photoaged skin |
JP2002293739A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Skin function-improving agent |
JP2002293740A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Hyaluronidase activity inhibitor |
CN100358884C (en) * | 2005-01-25 | 2008-01-02 | 上海奥利实业有限公司 | Simple synthesis of kojic acid diester |
JP2021517117A (en) * | 2018-03-08 | 2021-07-15 | シムライズ アーゲー | Mixtures for the treatment of human skin and / or hair |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62108804A (en) * | 1985-11-06 | 1987-05-20 | Pola Chem Ind Inc | Cosmetic |
-
1987
- 1987-10-12 JP JP62256736A patent/JP2575417B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62108804A (en) * | 1985-11-06 | 1987-05-20 | Pola Chem Ind Inc | Cosmetic |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06256151A (en) * | 1993-03-01 | 1994-09-13 | Maruzen Pharmaceut Co Ltd | Skin cosmetic |
JP2002293738A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Cosmetic for improving photoaged skin |
JP2002293739A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Skin function-improving agent |
JP2002293740A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Hyaluronidase activity inhibitor |
CN100358884C (en) * | 2005-01-25 | 2008-01-02 | 上海奥利实业有限公司 | Simple synthesis of kojic acid diester |
JP2021517117A (en) * | 2018-03-08 | 2021-07-15 | シムライズ アーゲー | Mixtures for the treatment of human skin and / or hair |
Also Published As
Publication number | Publication date |
---|---|
JP2575417B2 (en) | 1997-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920003328B1 (en) | Whitening cosmetic composition | |
KR940000671B1 (en) | Compositions for topical use having melanin synthesis-inhibiting activity | |
JPS63188609A (en) | External preparation preventing coloring | |
JPH0725742A (en) | Fair-skinning cosmetic | |
JPH07149612A (en) | Composition for toilet article or dermatology | |
JP3597210B2 (en) | Hair restoration | |
JP2844103B2 (en) | External preparation for skin | |
JPH01100113A (en) | External preparation for skin | |
JPH01100114A (en) | External preparation for skin | |
JP2565516B2 (en) | Topical skin | |
JPH0899860A (en) | Skin external agent | |
JPS60116618A (en) | Cosmetic | |
JPH0551314A (en) | Skin cosmetics | |
JPH04321615A (en) | Skin medicine for external use | |
JPS6231975B2 (en) | ||
JPS6256411A (en) | Beautifying agent | |
JPH10182404A (en) | Preparation for external use for skin | |
JP2906269B2 (en) | External preparation for skin | |
JP2000256173A (en) | Emulsified cosmetic | |
JP2589761B2 (en) | Cosmetic additives | |
JPH03200708A (en) | Dermal external agent | |
JP2000191499A (en) | Cosmetic for moisturiztng skin | |
JP2799600B2 (en) | Oily cosmetic for skin | |
JPH0635378B2 (en) | Cosmetics | |
JPH0363207A (en) | Skin cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |